Tripathi A, Chauhan S, Khasa R
Viruses. 2025; 17(1).
PMID: 39861863
PMC: 11769230.
DOI: 10.3390/v17010074.
Khan M, Islam R, Jerin T, Mahmud A, Khatun S, Kobir A
PLoS One. 2021; 16(6):e0253393.
PMID: 34138958
PMC: 8211291.
DOI: 10.1371/journal.pone.0253393.
Araujo S, Pereira L, Alves R, Andreata-Santos R, Kanno A, Ferreira L
Vaccines (Basel). 2020; 8(3).
PMID: 32878023
PMC: 7564369.
DOI: 10.3390/vaccines8030492.
Ku M, Anna F, Souque P, Petres S, Prot M, Simon-Loriere E
Mol Ther. 2020; 28(8):1772-1782.
PMID: 32485138
PMC: 7403329.
DOI: 10.1016/j.ymthe.2020.05.016.
Mada P, Sneed P, Castano G, Moore M, Joel Chandranesan A
Int J Microbiol. 2020; 2020:3513859.
PMID: 32454831
PMC: 7231183.
DOI: 10.1155/2020/3513859.
Role of NS1 and TLR3 in Pathogenesis and Immunity of WNV.
Patel S, Sinigaglia A, Barzon L, Fassan M, Sparber F, LeibundGut-Landmann S
Viruses. 2019; 11(7).
PMID: 31277274
PMC: 6669597.
DOI: 10.3390/v11070603.
Immunization with a suicidal DNA vaccine expressing the E glycoprotein protects ducklings against duck Tembusu virus.
Tang J, Bi Z, Ding M, Yin D, Zhu J, Zhang L
Virol J. 2018; 15(1):140.
PMID: 30217161
PMC: 6137926.
DOI: 10.1186/s12985-018-1053-0.
An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.
Acharya D, Bai F
Methods Mol Biol. 2016; 1435:249-91.
PMID: 27188563
PMC: 7120145.
DOI: 10.1007/978-1-4939-3670-0_19.
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
Van Hoeven N, Joshi S, Nana G, Bosco-Lauth A, Fox C, Bowen R
PLoS One. 2016; 11(2):e0149610.
PMID: 26901122
PMC: 4762984.
DOI: 10.1371/journal.pone.0149610.
Risk factors for West Nile virus infection and disease in populations and individuals.
Montgomery R, Murray K
Expert Rev Anti Infect Ther. 2015; 13(3):317-25.
PMID: 25637260
PMC: 4939899.
DOI: 10.1586/14787210.2015.1007043.
Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.
Verstrepen B, Oostermeijer H, Fagrouch Z, van Heteren M, Niphuis H, Haaksma T
PLoS One. 2014; 9(11):e112568.
PMID: 25392925
PMC: 4231036.
DOI: 10.1371/journal.pone.0112568.
Integrin β3 is required in infection and proliferation of classical swine fever virus.
Li W, Wang G, Liang W, Kang K, Guo K, Zhang Y
PLoS One. 2014; 9(10):e110911.
PMID: 25340775
PMC: 4207786.
DOI: 10.1371/journal.pone.0110911.
Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.
Tinker J, Yan J, Knippel R, Panayiotou P, Cornell K
Toxins (Basel). 2014; 6(4):1397-418.
PMID: 24759174
PMC: 4014742.
DOI: 10.3390/toxins6041397.
Current trends in West Nile virus vaccine development.
Amanna I, Slifka M
Expert Rev Vaccines. 2014; 13(5):589-608.
PMID: 24689659
PMC: 4279923.
DOI: 10.1586/14760584.2014.906309.
A recombinant novirhabdovirus presenting at the surface the E Glycoprotein from West Nile Virus (WNV) is immunogenic and provides partial protection against lethal WNV challenge in BALB/c mice.
Nzonza A, Lecollinet S, Chat S, Lowenski S, Merour E, Biacchesi S
PLoS One. 2014; 9(3):e91766.
PMID: 24663075
PMC: 3963854.
DOI: 10.1371/journal.pone.0091766.
Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.
Cielens I, Jackevica L, Strods A, Kazaks A, Ose V, Bogans J
Mol Biotechnol. 2014; 56(5):459-69.
PMID: 24570176
DOI: 10.1007/s12033-014-9743-3.
The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.
Lee P, Mukherjee S, Edeling M, Dowd K, Austin S, Manhart C
J Virol. 2013; 87(24):13729-40.
PMID: 24109224
PMC: 3838241.
DOI: 10.1128/JVI.02340-13.
Vaccines in development against West Nile virus.
Brandler S, Tangy F
Viruses. 2013; 5(10):2384-409.
PMID: 24084235
PMC: 3814594.
DOI: 10.3390/v5102384.
Role of natural killer and Gamma-delta T cells in West Nile virus infection.
Wang T, Welte T
Viruses. 2013; 5(9):2298-310.
PMID: 24061543
PMC: 3798903.
DOI: 10.3390/v5092298.
A review of vaccine approaches for West Nile virus.
Iyer A, Kousoulas K
Int J Environ Res Public Health. 2013; 10(9):4200-23.
PMID: 24025396
PMC: 3799512.
DOI: 10.3390/ijerph10094200.